Latest News & Features
Americas
Obviousness-type double patenting is a serious consideration that patent owners should keep in mind during the examination of an application or in performing due diligence on a patent portfolio, says MaryAnne Armstrong. 20 June 2014
Generics
There is no uniform interpretation of the scope of the Bolar exemption in Europe, but a CJEU opinion harmonising the issue may be on the way, says Rafal Witek. 20 June 2014
Americas
More than 15,000 life sciences industry professionals will arrive in San Diego this month for the annual BIO International Convention. LSIPR looks at some of the most interesting sessions, and talks to a couple of speakers. 20 June 2014
Americas
Holland & Knight LLP has expanded its IP practice group with the hire of patent litigator Howard Suh as partner. 18 June 2014
Americas
Stem cell research companies in Canada and Australia have teamed up to support increased research and development in both countries. 16 June 2014
Americas
Drug giant Merck is to acquire biopharmaceutical company Idenix for $24.50 per share, valuing the purchase at around $3.85 billion. 12 June 2014
Big Pharma
Law firm Dechert LLP has appointed Rüdiger Herrmann as a partner in its Frankfurt office. 10 June 2014
Generics
Irish-based drug manufacturer Actavis has settled its patent dispute with Zydus Pharmaceuticals. 10 June 2014
Americas
AMAG Pharmaceuticals, Inc. has had a US patent covering ferumoxytol extended. 9 June 2014
Biotechnology
Kite Pharma, a biotech company, has entered into a licensing agreement with the US’s National Institute of Health that will give it the IP rights to T-cell therapies developed to treat cancer. 9 June 2014